Shots:
- The collaboration will deploy Biofourmis’ Biovitals platform to co-develop a novel digital technology for the objective assessment of pain using biosensors and AI-based algorithms. The solutions will be validated in the global study that enrolls 120+ endometriosis patients
- The digital solution for managing patients with endometriosis in an ambulatory setting will include a wearable, clinical-grade biosensor to capture physiology biomarkers and a mobile app to monitor symptoms, with a gamification engine for patient engagement
- The technology applies analytics to physiology biomarkers for quantification of pain and will include a clinician-facing web dashboard for remote review and intervention. Chugai is demonstrating its commitment to applying the advanced digital technologies for better understanding the real-life needs of patients and to develop innovative solutions for society, as outlined in the CHUGAI DIGITAL VISION 2030
Click here to read full press release/ article | Ref: PRNewswire | Image: Biofourmis
